Phrenic Nerve Interventions for the Prevention and Management of Prolonged Air Leak and Residual Pleural Space After Pulmonary Resection: A Structured Narrative Review.
6 affiliations
- 1Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 1 December Sq., 410081 Oradea, Romania.
- 2Department of Surgical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 1st University Street, 410087 Oradea, Romania.
- 3Discipline of Surgical Semiology 1, Thoracic Surgery, University of Medicine and Pharmacy Victor Babes, 300041 Timisoara, Romania.
- 4Department of Psycho-Neurosciences and Recovery, Faculty of Medicine and Pharmacy, University of Oradea, 1 December Sq., 410081 Oradea, Romania.
- 5Pharmacy Department, Faculty of Medicine and Pharmacy, University of Oradea, 1 December Sq., 410081 Oradea, Romania.
- 6Faculty of Medicine and Pharmacy, University of Oradea, 1 December Sq., 410081 Oradea, Romania.
Abstract
Background and Objectives: Prolonged air leak (PAL) and residual pleural space (RPS) remain frequent complications after pulmonary resection. Temporary phrenic nerve modulation has been proposed to reduce pleural cavity volume by elevating the ipsilateral hemidiaphragm. Materials and Methods: This structured narrative review searched PubMed/MEDLINE, Scopus, and Google Scholar from inception to 30 June 2026 and screened reference lists. Direct evidence was defined as human post-resection studies reporting PAL, air-leak duration, drainage duration, or RPS; shoulder-pain, interscalene-block, historical, and preclinical studies were retained only as indirect mechanistic, technical, or safety context. Randomized trials and case series were appraised using RoB 2 and the JBI case-series tool, respectively. Results: Direct clinical evidence comprises three single-center randomized trials and two small uncontrolled case series. Pharmacological blockade has demonstrated recovery after discontinuation in the available clinical studies, and cryoneuroablation trials reported recovery within 30-60 days to three months. Evidence of reversibility and clinical safety remains insufficient for historical mechanical compression, which has been associated with persistent dysfunction, and for botulinum toxin, which has not been evaluated in humans for this indication. The two cryoneuroablation trials reported discordant primary results; differences in patient risk, surgical era, and outcome measurement are hypotheses rather than established explanations. No head-to-head comparison between phrenic techniques or against established space-reduction methods is available. Conclusions: Phrenic nerve modulation is biologically plausible and clinically promising in selected research populations, but the evidence is too limited and heterogeneous to support routine use or comparative recommendations. Future multicenter trials should mandate validated PAL-risk stratification, prespecified respiratory-reserve criteria, standardized PAL/RPS outcomes, and time-to-resolution or digital air-leak measures.
Related
- Digital, Mobile and Artificial Intelligence‐Supported Interventions for Pressure Injury Prevention and Management: A Systematic Review of Clinical, Workflow and Implementation Outcomes
- Perioperative Interventions for Prevention of Prolonged Postoperative Ileus and Gastrointestinal Recovery After Colorectal Surgery: A Systematic Review of Randomized Controlled Trials
- Bayesian multistate modelling of prefrailty and frailty using microsimulation with weight management interventions for prevention in Asian settings
- Core components of physical activity interventions in the prevention and management of breast cancer-related lymphoedema (BCRL): A scoping review
- Pulmonary thromboembolism with prolonged pulmonary infarction during intensive decongestion for severe heart failure : A case report
BibTeX
@article{feher2026phrenic,
title = {{Phrenic Nerve Interventions for the Prevention and Management of Prolonged Air Leak and Residual Pleural Space After Pulmonary Resection: A Structured Narrative Review.}},
author = {László Fehér and Mircea Ioan Șandor and Gabriel Veniamin Cozma and Cristian Marius Daina and Timea Claudia Ghitea and Rareș Cristian Daina and Mădălina Diana Fehér},
journal = {Medicina (Kaunas, Lithuania)},
year = {2026},
month = sep,
doi = {10.3390/medicina62101863},
url = {https://europepmc.org/article/MED/42942394},
note = {CC BY},
}
RIS
TY - JOUR
TI - Phrenic Nerve Interventions for the Prevention and Management of Prolonged Air Leak and Residual Pleural Space After Pulmonary Resection: A Structured Narrative Review.
AU - László Fehér
AU - Mircea Ioan Șandor
AU - Gabriel Veniamin Cozma
AU - Cristian Marius Daina
AU - Timea Claudia Ghitea
AU - Rareș Cristian Daina
AU - Mădălina Diana Fehér
PY - 2026
DA - 2026/09/25
JO - Medicina (Kaunas, Lithuania)
DO - 10.3390/medicina62101863
UR - https://europepmc.org/article/MED/42942394
AB - Background and Objectives: Prolonged air leak (PAL) and residual pleural space (RPS) remain frequent complications after pulmonary resection. Temporary phrenic nerve modulation has been proposed to reduce pleural cavity volume by elevating the ipsilateral hemidiaphragm. Materials and Methods: This structured narrative review searched PubMed/MEDLINE, Scopus, and Google Scholar from inception to 30 June 2026 and screened reference lists. Direct evidence was defined as human post-resection studies reporting PAL, air-leak duration, drainage duration, or RPS; shoulder-pain, interscalene-block, historical, and preclinical studies were retained only as indirect mechanistic, technical, or safety context. Randomized trials and case series were appraised using RoB 2 and the JBI case-series tool, respectively. Results: Direct clinical evidence comprises three single-center randomized trials and two small uncontrolled case series. Pharmacological blockade has demonstrated recovery after discontinuation in the available clinical studies, and cryoneuroablation trials reported recovery within 30-60 days to three months. Evidence of reversibility and clinical safety remains insufficient for historical mechanical compression, which has been associated with persistent dysfunction, and for botulinum toxin, which has not been evaluated in humans for this indication. The two cryoneuroablation trials reported discordant primary results; differences in patient risk, surgical era, and outcome measurement are hypotheses rather than established explanations. No head-to-head comparison between phrenic techniques or against established space-reduction methods is available. Conclusions: Phrenic nerve modulation is biologically plausible and clinically promising in selected research populations, but the evidence is too limited and heterogeneous to support routine use or comparative recommendations. Future multicenter trials should mandate validated PAL-risk stratification, prespecified respiratory-reserve criteria, standardized PAL/RPS outcomes, and time-to-resolution or digital air-leak measures.
SN - 1010-660X
SN - 1648-9144
ER -